Investigation of lysine side chain interactions of interleukin-8 with heparin and other glycosaminoglycans studied by a methylation-NMR approach

Glycobiology

Volumn 23, Issue 11, 2013, Pages 1260-1269

  Möbius, Kristin ^a   Nordsieck, Karoline ^a   Pichert, Annelie ^a   Samsonov, Sergey A ^b   Thomas, Lars ^a   Schiller, Jürgen ^a   Kalkhof, Stefan ^c   Teresa Pisabarro, M ^b   Beck Sickinger, Annette G ^a   Huster, Daniel ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c HELMHOLTZ CENTRE FOR ENVIRONMENTAL RESEARCH UFZ   (Germany)

Author keywords

Chemokine; Electrostatics; Nmr; Protein glycosaminoglycan interaction; Reductive methylation

Indexed keywords

AMINE; ARGININE; CARBON 13; GLYCOSAMINOGLYCAN; GUANIDINE; HEPARIN; INTERLEUKIN 8; LYSINE;

ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; FLUORESCENCE SPECTROSCOPY; MASS SPECTROMETRY; METHYLATION; MOLECULAR DOCKING; MOLECULAR DYNAMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN CARBOHYDRATE INTERACTION; SITE DIRECTED MUTAGENESIS; TITRIMETRY;

CHEMOKINE; ELECTROSTATICS; NMR; PROTEIN/GLYCOSAMINOGLYCAN INTERACTION; REDUCTIVE METHYLATION;

AMINO ACID SUBSTITUTION; ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; GLYCOSAMINOGLYCANS; HEPARIN; INTERLEUKIN-8; LYSINE; MAGNETIC RESONANCE SPECTROSCOPY; METHYLATION; MOLECULAR DYNAMICS SIMULATION; OXIDATION-REDUCTION; PROTEIN BINDING; RECEPTORS, INTERLEUKIN-8A; SIGNAL TRANSDUCTION; SOLUTIONS;

EID: 84886061681     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwt062     Document Type: Article

References (39)

1. Baggiolini M, Dewald B, Moser B. 1994. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol. 55:97-179.
2. Bitomsky W, Wade RC. 1999. Docking of glycosaminoglycans to heparinbinding proteins: Validation for aFGF, bFGF, and antithrombin and application to IL-8. J Am Chem Soc. 121:3004-3013. (Pubitemid 29189745)
3. Bokoch MP, Zou Y, Rasmussen SG, Liu CW, Nygaard R, Rosenbaum DM, Fung JJ, Choi HJ, Thian FS, Kobilka TS, Puglisi JD, Weis WI, Pardo L, Prosser RS, Mueller L, Kobilka BK. 2010. Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor. Nature. 463:108-112.
4. Case DA, Darden TA, Cheatham TE, III, Simmerling CL, Wang J, Duke RE, Luo R, Walker RC, Zhank W, Merz KM, Roberts B, Wang B, Hayik S, Roitberg A, Seabra G, Kolossváry I, Wong KF, Paesani F, Vanicek J, Liu J, Wu X, Brozell SR, Steinbrecher T, Gohlke H, Cai Q, Ye X, Wang J, Hsieh MJ, Cui G, Roe DR, Mathews DH, Seetin MG, Sagui C, Babin T, Luchko T, Gusarov S, Kovalenko A, Kollman PA. AMBER 11. 2010. Protein NMR Spectroscopy. Principles and Practice. San Francisco: University of California.
5. Cavanagh J, Fairbrother WJ, Palmer AG, III, Skelton NJ. 1996. Protein NMR Spectroscopy. Principles and Practice. San Diego: Academic Press.
6. Chong S, Mersha FB, Comb DG, Scott ME, Landry D, Vence LM, Perler FB, Benner J, Kucera RB, Hirvonen CA, Pelletier JJ, Paulus H, Xu MQ. 1997. Single-column purification of free recombinant proteins using a selfcleavable affinity tag derived from a protein splicing element. Gene. 192:271-281. (Pubitemid 27268252)
7. David R, Gunther R, Baumann L, Luhmann T, Seebach D, Hofmann HJ, Beck-Sickinger AG. 2008. Artificial chemokines: Combining chemistry and molecular biology for the elucidation of interleukin-8 functionality. J Am Chem Soc. 130:15311-15317.
8. Daze KD, Hof F. 2013. The cation-pi interaction at protein-protein interaction interfaces: Developing and learning from synthetic mimics of proteins that bind methylated lysines. Acc Chem Res. 46:937-945.
9. Dupradeau FY, Pigache A, Zaffran T, Savineau C, Lelong R, Grivel N, Lelong D, Rosanski W, Cieplak P. 2010. The R.E.D. tools: Advances in RESP and ESP charge derivation and force field library building. Phys Chem Chem Phys. 12:7821-7839.
10. Fielding L. 2007. NMR methods for the determination of protein-ligand dissociation constants. Prog Nucl Magn Reson Spectrosc. 51:219-242. (Pubitemid 350064300)
11. Gandhi NS, Mancera RL. 2008. The structure of glycosamininoglycans and their interaction with proteins. Chem Biol Drug Des. 72:455-482.
12. Hoogewerf AJ, Kuschert GS, Proudfoot AE, Borlat F, Clark-Lewis I, Power CA, Wells TN. 1997. Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry. 36:13570-13578. (Pubitemid 27481603)
13. Huige CJM, Altona C. 1995. Force-field parameters for sulfates and sulfamates based on ab-initio calculations - extensions of Amber and CHARMM fields. Jr Comput Chem. 16:56-79.
14. Imberty A, Lortat-Jacob H, Perez S. 2007. Structural view of glycosaminoglycanprotein interactions. Carbohydr Res. 342:430-439.
15. Jackson RL, Busch SJ, Cardin AD. 1991. Glycosaminoglycans: Molecular properties, protein interactions, and role in physiological processes. Physiol Rev. 71:481-539.
16. Kadirvelraj R, Foley BL, Dyekjaer JD, Woods RJ. 2008. Involvement of water in carbohydrate-protein binding: Concanavalin A revisited. J Am Chem Soc. 130:16933-16942.
17. Krieger E, Geretti E, Brandner B, Goger B, Wells TN, Kungl AJ. 2004. A structural and dynamic model for the interaction of interleukin-8 and glycosaminoglycans: Support from isothermal fluorescence titrations. Proteins. 54:768-775. (Pubitemid 38298795)
18. Künze G, Barre P, Scheidt HA, Thomas L, Eliezer D, Huster D. 2012. Binding of the three-repeat domain of tau to phospholipid membranes induces an aggregated-like state of the protein. Biochim Biophys Acta. 1818:2302-2313.
19. Kuschert GS, Hoogewerf AJ, Proudfoot AE, Chung CW, Cooke RM, Hubbard RE, Wells TN, Sanderson PN. 1998. Identification of a glycosaminoglycan binding surface on human interleukin-8. Biochemistry. 37:11193-11201. (Pubitemid 28394867)
20. Ladokhin AS, Jayasinghe S, White SH. 2000. How to measure and analyze tryptophan fluorescence in membranes properly, and why bother? Anal Biochem. 285:235-245.
21. Larda ST, Bokoch MP, Evanics F, Prosser RS. 2012. Lysine methylation strategies for characterizing protein conformations by NMR. J Biomol NMR. 54:199-209.
22. Ley K, Laudanna C, Cybulsky MI, Nourshargh S. 2007. Getting to the site of inflammation: The leukocyte adhesion cascade updated. Nat Rev Immunol. 7:678-689. (Pubitemid 47327397)
23. Liu ML, Mao XA, Ye CH, Huang H, Nicholson JK, Lindon JC. 1998. Improved WATERGATE pulse sequences for solvent suppression in NMR spectroscopy. J Magn Reson. 132:125-129. (Pubitemid 128450594)
24. Lortat-Jacob H, Grosdidier A, Imberty A. 2002. Structural diversity of heparan sulfate binding domains in chemokines. Proc Natl Acad Sci USA. 99:1229-1234. (Pubitemid 34136475)
25. Means GE, Feeney RE. 1968. Reductive alkylation of amino groups in proteins. Biochemistry. 7:2192-2201.
26. Mori S, Abeygunawardana C, Johnson MO, Vanzijl PCM. 1995. Improved sensitivity of HSQC spectra of exchanging protons at short Interscan delays using a new fast HSQC (FHSQC) detection scheme that avoids water saturation. J Magn Reson B. 108:94-98.
27. Mortier A, Van DJ, Proost P. 2008. Regulation of chemokine activity by posttranslational modification. Pharmacol Ther. 120:197-217.
28. Nordsieck K, Pichert A, Samsonov SA, Thomas L, Berger C, Pisabarro MT, Huster D, Beck-Sickinger AG. 2012. Residue 75 of interleukin-8 is crucial for its interactions with glycosaminoglycans. Chem Bio Chem. 13:2558-2566.
29. Pichert A, Samsonov SA, Theisgen S, Thomas L, Baumann L, Schiller J, Beck-Sickinger AG, Huster D, Pisabarro MT. 2012. Characterization of the interaction of interleukin-8 with hyaluronan, chondroitin sulfate, dermatan sulfate and their sulfated derivatives by spectroscopy and molecular modeling. Glycobiology. 22:134-145.
30. Prestwich GD. 2011. Hyaluronic acid-based clinical biomaterials derived for cell and molecule delivery in regenerative medicine. J Control Release. 155:193-199.
31. Rayment I. 1997. Reductive alkylation of lysine residues to alter crystallization properties of proteins. Methods Enzymol. 276:171-179. (Pubitemid 27085603)
32. Rypniewski WR, Holden HM, Rayment I. 1993. Structural consequences of reductive methylation of lysine residues in hen egg white lysozyme: An X-ray analysis at 1.8-A resolution. Biochemistry. 32:9851-9858. (Pubitemid 23296833)
33. Salbach J, Rachner TD, Rauner M, Hempel U, Anderegg U, Franz S, Simon JC, Hofbauer LC. 2012. Regenerative potential of glycosaminoglycans for skin and bone. J Mol Med (Berl). 90:625-635.
34. Schiller J, Huster D. 2012. New methods to study the composition and structure of the extracellular matrix in natural and bioengineered tissues. Biomatter. 2:115-131.
35. Schlorke D, Thomas L, Samsonov SA, Huster D, Arnhold J, Pichert A. 2012. The influence of glycosaminoglycans on IL-8-mediated functions of neutrophils. Carbohydr Res. 356:196-203.
36. Senni K, Pereira J, Gueniche F, barre-Ladrat C, Sinquin C, Ratiskol J, Godeau G, Fischer AM, Helley D, Colliec-Jouault S. 2011. Marine polysaccharides: A source of bioactive molecules for cell therapy and tissue engineering. Mar Drugs. 9:1664-1681.
37. Theisgen S, Thomas L, Schroder T, Lange C, Kovermann M, Balbach J, Huster D. 2011. The presence of membranes or micelles induces structural changes of the myristoylated guanylate-cyclase activating protein-2. Eur Biophys J. 40:565-576.
38. Walter TS, Meier C, Assenberg R, Au KF, Ren J, Verma A, Nettleship JE, Owens RJ, Stuart DI, Grimes JM. 2006. Lysine methylation as a routine rescue strategy for protein crystallization. Structure. 14:1617-1622. (Pubitemid 46110803)
39. Ziarek JJ, Veldkamp CT, Zhang F, Murray NJ, Kartz GA, Liang X, Su J, Baker JE, Linhardt RJ, Volkman BF. 2013. Heparin oligosaccharides inhibit chemokine (CXC motif) ligand 12 (CXCL12) cardioprotection by binding orthogonal to the dimerization interface, promoting oligomerization, and competing with the chemokine (CXC motif) receptor 4 (CXCR4) N terminus. J Biol Chem. 288:737-746.